Catalyst Wire Dossier Catalyst Wire Dossier

Porphozym

· Zymenex A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Porphozym, covering 2018-03-09 to 2018-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Porphozym in the Treatment of Acute Attacks in AIP [Phase 2, Phase 3]

See pricing